SCHEDULE 13G/AFiled Mar 4, 7:00 PM ET

ArriVent BioPharma, Inc. SCHEDULE 13G/A

Sofinnova Venture Partners IX, L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.